Building the global infrastructure for regenerative medicine
An integrated platform connecting biotechnology, physician education, clinical application and global distribution.
The RMTG Platform
Through Global Stem Cells Group and its operating businesses, RMTG connects the scientific, educational, manufacturing, clinical and commercial capabilities required to advance regenerative medicine — from knowledge to application.
Learn more about our platform
Regenerative Medical Technology Groupwww.rmtg.comGlobal Stem Cells Group
Operating Platform
Physician education, certification, hands-on training and a global scientific community.
Learn more
Biotechnology and product innovation with in-house cGMP manufacturing and quality you can trust.
Learn more
Flagship clinical institute delivering regenerative medicine with patient-centered care.
Learn more
A continuous cycle that drives growth
A Platform Designed for Scale
Vertical Integration
Participating across multiple segments of the regenerative medicine value chain.
Multiple Revenue Channels
Education, products, clinical services, provider network and international distribution.
Established Infrastructure
Existing businesses with proven operations, capabilities and industry relationships.
Global Physician Ecosystem
Connecting physicians and professionals across international markets.
Expansion Platform
Foundation for organic growth, new markets, strategic partnerships and acquisitions.
Strategic Sponsorship
Advancing athlete recovery through regenerative medicine.
RMTG is proud to sponsor Bare Knuckle Fighting Championship, connecting our regenerative medicine platform with one of the world's most dynamic combat-sports organizations. The collaboration reflects RMTG's expanding visibility and its commitment to advancing the conversation around athlete health, recovery, and long-term performance.
Where elite performance meets the future of recovery.
From the arena to the lab
“We built RMTG so that education, manufacturing, clinical care and distribution operate as one connected platform — and give public-market investors access to it.”
Our focus is disciplined execution across the four divisions and clear communication with shareholders as an SEC reporting company.
Dave Christensen
CEO and President, Regenerative Medical Technology Group Inc.
RMTG at a glance*
- 30+
- Countries Reached
- 10,000+
- Physicians Trained
- 100+
- International Events
- 1,400+
- Verified Providers
- 200+
- Network Locations
- 15+
- Years of Industry Experience
*Metrics represent aggregated information across Global Stem Cells Group and its operating businesses. Figures are indicative and provided for reference.
Latest News
View all newsOTC: RMTG
Delayed · reference only
Chart is illustrative — not historical price data
View all investor resourcesA proprietary intelligence layer across the entire platform
ISSCA AI is our in-house clinical intelligence technology, developed to turn complex biomarker and treatment data into structured insight. It is one example of how RMTG builds defensible, differentiated capabilities across the ecosystem — extending the reach of every clinic, physician and partner in the network.
Intelligent biomarker interpretation
Turn raw lab panels into clear, contextual clinical meaning in real time.
Trend analysis across time and panels
Track longitudinal change across biomarkers to anticipate patient trajectories.
Automated clinical summaries
Generate structured, physician-ready summaries and reports automatically.
Exportable patient insights
Share clear, exportable insights that support patient communication.
Secure, compliant data handling
Built for the privacy and compliance standards clinical data demands.
Preventive & regenerative focus
Purpose-built for preventive, regenerative and longevity-focused medicine.
Product details, capabilities and demos are available on the platform's dedicated site. Visit issca.com
Partner. Invest. Transform.
RMTG is building the infrastructure for a new era in medicine. We invite physicians, partners and investors to join us in transforming regenerative medicine from knowledge into global application.
